Beyond Omalizumab: Emerging Biologic and Small Molecule Therapies in Chronic Spontaneous Urticaria.

Kaur S, Kumaran MS, Singh S, Parsad D

Open source

DOI
10.1111/cea.70437
Published
2026 Sep 22
Container
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cea.70437,
  title = {Beyond Omalizumab: Emerging Biologic and Small Molecule Therapies in Chronic Spontaneous Urticaria.},
  author = {Kaur S and Kumaran MS and Singh S and Parsad D},
  year = {2026},
  journal = {Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology},
  doi = {10.1111/cea.70437},
  url = {https://doi.org/10.1111/cea.70437}
}

RIS

TY  - JOUR
TI  - Beyond Omalizumab: Emerging Biologic and Small Molecule Therapies in Chronic Spontaneous Urticaria.
AU  - Kaur S
AU  - Kumaran MS
AU  - Singh S
AU  - Parsad D
PY  - 2026
JO  - Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
DO  - 10.1111/cea.70437
UR  - https://doi.org/10.1111/cea.70437
ER  - 

APA

S, K., MS, K., S, S., & D, P. (2026). Beyond Omalizumab: Emerging Biologic and Small Molecule Therapies in Chronic Spontaneous Urticaria.. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. https://doi.org/10.1111/cea.70437

Source records